Senior insider sale
Chief Discovery Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$2.71M
82.34K shares
What this filing means
KREITZER ANATOL plans to sell 82.34K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $2.71M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2026ACC: 0001193125-26-305146
Officer· Chief Discovery Officer
Since Feb 2026
82.34K
Shares to sell
$2.71M
Approx. market value
33.60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock unit settlement
N/A
7/15/2026
33.60KTotal acquired33.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2026 | Restricted stock unit settlement N/A | 33.60K | — |
| Total | 33.60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
45.42K
Market value
$1.35M
4/27/2026
—Completed
Units to sell
3.32K
Market value
$88.2K
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
33.60K
Market value
$1.27M
7/15/2026
Total
Units
82.34K
Value
$2.71M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/27/2026 | 45.42K | $1.35M | — | Completed |
4/15/2026 | 3.32K | $88.2K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 33.60K | $1.27M | Nasdaq | Planned |
| Total | 82.34K | $2.71M | ||